"100% efficacy of the vaccine for Astrazeneca / Oxford Irbm in avoiding hospitalization: the preprint delivered to The Lancet of a study on 10,290 people in England and 10,300 in Brazil aged 18 and over and therefore including the elderly also with serious pathologies such as diabetes, obesity, respiratory insufficiency and cardiovascular problems, it undoubtedly clarifies that the effectiveness in contrasting serious disease is 100% ".
This was stated by Pietro Di Lorenzo, president of Irbm, in an interview with ANSA.
"This means that all vaccinated people are no longer in danger of going to hospital or intensive care."
"By the end of February, one million doses of the Oxford / AstraZeneca / Irbm vaccine will arrive
. In March, if there are no particular problems, a
further 4 million doses
are expected to be delivered
. In the following months, given the organizational effort it is putting in place. Astrazeneca field, it is credible that we can also hypothesize a recovery of part of the missed deliveries ".
This was stated by Pietro Di Lorenzo, president of the Irbm of Pomezia, in an interview with ANSA.